These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 3729947

  • 1. B16 tumor cells contain a warfarin sensitive vitamin K1 2,3 epoxide reductase.
    Uitendaal MP, Thijssen HH, Drittij-Reijnders MJ, Hoeijmakers MJ.
    Biochem Biophys Res Commun; 1986 Jun 30; 137(3):1015-20. PubMed ID: 3729947
    [Abstract] [Full Text] [Related]

  • 2. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
    Wilson CR, Sauer JM, Carlson GP, Wallin R, Ward MP, Hooser SB.
    Toxicology; 2003 Aug 01; 189(3):191-8. PubMed ID: 12832152
    [Abstract] [Full Text] [Related]

  • 3. Assembly of the warfarin-sensitive vitamin K 2,3-epoxide reductase enzyme complex in the endoplasmic reticulum membrane.
    Cain D, Hutson SM, Wallin R.
    J Biol Chem; 1997 Nov 14; 272(46):29068-75. PubMed ID: 9360981
    [Abstract] [Full Text] [Related]

  • 4. Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.
    Thijssen HH, Janssen YP, Vervoort LT.
    Biochem J; 1994 Jan 15; 297 ( Pt 2)(Pt 2):277-80. PubMed ID: 8297331
    [Abstract] [Full Text] [Related]

  • 5. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
    Fasco MJ, Principe LM, Walsh WA, Friedman PA.
    Biochemistry; 1983 Nov 22; 22(24):5655-60. PubMed ID: 6652076
    [Abstract] [Full Text] [Related]

  • 6. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
    Lee JJ, Principe LM, Fasco MJ.
    Biochemistry; 1985 Dec 03; 24(25):7063-70. PubMed ID: 4084561
    [Abstract] [Full Text] [Related]

  • 7. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
    Fasco MJ, Hildebrandt EF, Suttie JW.
    J Biol Chem; 1982 Oct 10; 257(19):11210-2. PubMed ID: 6811577
    [Abstract] [Full Text] [Related]

  • 8. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.
    Mukharji I, Silverman RB.
    Proc Natl Acad Sci U S A; 1985 May 10; 82(9):2713-7. PubMed ID: 3857611
    [Abstract] [Full Text] [Related]

  • 9. Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.
    Thijssen HH, Drittij-Reijnders MJ.
    Br J Haematol; 1993 Aug 10; 84(4):681-5. PubMed ID: 8217828
    [Abstract] [Full Text] [Related]

  • 10. Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.
    Guenthner TM, Cai D, Wallin R.
    Biochem Pharmacol; 1998 Jan 15; 55(2):169-75. PubMed ID: 9448739
    [Abstract] [Full Text] [Related]

  • 11. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA, Suttie JW.
    Thromb Res; 1986 Oct 15; 44(2):147-53. PubMed ID: 3787564
    [Abstract] [Full Text] [Related]

  • 12. Vitamin K1 hydroquinone formation catalyzed by a microsomal reductase system.
    Fasco MJ, Principe LM.
    Biochem Biophys Res Commun; 1980 Dec 31; 97(4):1487-92. PubMed ID: 7213374
    [No Abstract] [Full Text] [Related]

  • 13. Vitamin K-dependent carboxylation and vitamin K metabolism in liver. Effects of warfarin.
    Wallin R, Martin LF.
    J Clin Invest; 1985 Nov 31; 76(5):1879-84. PubMed ID: 3932474
    [Abstract] [Full Text] [Related]

  • 14. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
    Preusch PC, Suttie JW.
    J Nutr; 1984 May 31; 114(5):902-10. PubMed ID: 6726460
    [Abstract] [Full Text] [Related]

  • 15. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
    Hildebrandt EF, Preusch PC, Patterson JL, Suttie JW.
    Arch Biochem Biophys; 1984 Feb 01; 228(2):480-92. PubMed ID: 6696443
    [Abstract] [Full Text] [Related]

  • 16. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
    Fasco MJ, Principe LM.
    J Biol Chem; 1982 May 10; 257(9):4894-901. PubMed ID: 7068669
    [Abstract] [Full Text] [Related]

  • 17. Formation of hydroxyvitamin K by vitamin K epoxide reductase of warfarin-resistant rats.
    Fasco MJ, Preusch PC, Hildebrandt E, Suttie JW.
    J Biol Chem; 1983 Apr 10; 258(7):4372-80. PubMed ID: 6833262
    [Abstract] [Full Text] [Related]

  • 18. Characterization and purification of the vitamin K1 2,3 epoxide reductases system from rat liver.
    Begent LA, Hill AP, Steventon GB, Hutt AJ, Pallister CJ, Cowell DC.
    J Pharm Pharmacol; 2001 Apr 10; 53(4):481-6. PubMed ID: 11341364
    [Abstract] [Full Text] [Related]

  • 19. Microsomal warfarin binding and vitamin K 2,3-epoxide reductase.
    Thijssen HH, Baars LG.
    Biochem Pharmacol; 1989 Apr 01; 38(7):1115-20. PubMed ID: 2706010
    [Abstract] [Full Text] [Related]

  • 20. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
    Preusch PC, Suttie JW.
    Arch Biochem Biophys; 1984 Nov 01; 234(2):405-12. PubMed ID: 6497379
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.